Range
- - -
Vol / Avg.
-/2.5M
Div / Yield
-
52 Wk
1.82 - 5.7
Mkt Cap
152.2M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.11
Shares
58.1M
Outstanding
58.1M
Total Float
23.5M
load more
Sector: Health Care.Industry: Biotechnology
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-13
REV
Q1 2021Est.ActualSurprise
EPS-0.170-0.110 0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
GALTGalectin Therapeutics0%152.2M

Galectin Therapeutics Frequently Asked Questions

Q

How do I buy Galectin Therapeutics (GALT) stock?

A

You can purchase shares of Galectin Therapeutics (NASDAQ: GALT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Galectin Therapeutics's (GALT) competitors?

Q

What is the target price for Galectin Therapeutics (GALT) stock?

A

The latest price target for Galectin Therapeutics (NASDAQ: GALT) was reported by HC Wainwright & Co. on April 16, 2021. The analyst firm set a price target for 14.00 expecting GALT to rise to within 12 months (a possible 434.35% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Galectin Therapeutics (GALT)?

A

The stock price for Galectin Therapeutics (NASDAQ: GALT) is $2.62 last updated Thu Jul 29 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Galectin Therapeutics (GALT) pay a dividend?

A

There are no upcoming dividends for Galectin Therapeutics.

Q

When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?

A
Galectin Therapeutics’s Q2 earnings are confirmed for after-market on August 13, 2021.
Q

Is Galectin Therapeutics (GALT) going to split?

A

There is no upcoming split for Galectin Therapeutics.

Q

What sector and industry does Galectin Therapeutics (GALT) operate in?

A

Galectin Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.